Bildkälla: Stockfoto

BONESUPPORT Q4: Sales estimates beat again - Redeye

Redeye returns with a more in-depth take on BONESUPPORT’s Q4 report, rendering some changes to our financial estimates. We are encouraged by the US CERAMENT G sales in the quarter and up our estimates for this product in the US for 2023e. Moreover, we increase our fair value range considerably.

Redeye returns with a more in-depth take on BONESUPPORT’s Q4 report, rendering some changes to our financial estimates. We are encouraged by the US CERAMENT G sales in the quarter and up our estimates for this product in the US for 2023e. Moreover, we increase our fair value range considerably.
Börsvärldens nyhetsbrev
ANNONSER